Protein detail

CD2

T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2)

Entry name
CD2
UniProt ID
EVMP score
0.50
Frequency
1
Transmembrane count
1
Protein classification
CD markersFDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2)
Protein Class
CD markersFDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins
Protein Function
  • CD markers
  • Predicted intracellular proteins
  • FDA approved drug targets:Biotech drugs
Transmembrane
210..235; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym
SRBC
Gene Description
CD2 molecule
Chromosome
1
Position
116754430-116769229
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
CD2 fluorescence
Tissue Specificskin 1Cell SpecificDistal convoluted tubule cellsSingle-Nuclei Brain Specificchoroid plexus epithelial cellBlood Cell SpecificT-reg
Function & Pathway
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

50 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
transmembranetransmembraneRamilowski_locationNoNoNoYesNo
transmembranetransmembraneOmniPathNoNoNoYesNo
plasma_membraneplasma_membraneUniProt_locationNoNoNoYesNo
plasma_membraneplasma_membraneCellinkerNoNoNoYesNo
plasma_membraneplasma_membraneOmniPathNoNoNoYesNo
plasma_membrane_transmembraneplasma_membrane_transmembraneMembranomeNoNoNoYesNo
plasma_membrane_transmembraneplasma_membrane_transmembraneCSPANoNoNoYesNo
plasma_membrane_transmembraneplasma_membrane_transmembraneOmniPathNoNoNoYesNo
cell_surfacecell_surfaceSurfaceomeNoNoNoYesNo
cell_surfacecell_surfaceconnectomeDB2020NoNoNoYesNo
Page 4 of 5PreviousNext

Regulatory Interaction Network

0 records.

Protein Complex Composition

130 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
SWI/SNF ATP-dependent chromatin remodeling complexACTL6B-ARID1B-SMARCA4 variantACTBACTL6BARID1BSMARCA4SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3SMARCE1O94805P51532P60709Q12824Q6STE5Q8NFD5Q8TAQ2Q92922Q92925Q969G3Q96GM51:1:1:1:1:1:1:1:1:1:1ComplexPortalintact:EBI-16364506PDB:5gjk18809673117905589843504284086479845365126202262869582214755292108844061107398823644491
SWI/SNF complexACTL6AACTR1AACTR1BARID5BSMARCA2SMARCA4SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3YEATS4O95619O96019P42025P51531P51532P61163Q12824Q14865Q6STE5Q8TAQ2Q92922Q92925Q96GM51:1:1:1:1:1:1:1:1:1:1:1:1CompleatCompleat:HC99815506919
SWI/SNF-AACTL6AARID1ASMARCA2SMARCA4SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3SMARCE1O14497O96019P51531P51532Q12824Q6STE5Q8TAQ2Q92922Q92925Q969G3Q96GM51:1:1:1:1:1:1:1:1:1:1CompleatCompleat:HC74882234388208605880430798453657801128110739889435219
SWI/SNF-BACTL6AARID2PBRM1SMARCA4SMARCB1SMARCC1SMARCC2SMARCD1SMARCD2SMARCD3SMARCE1O96019P51532Q12824Q68CP9Q6STE5Q86U86Q8TAQ2Q92922Q92925Q969G3Q96GM51:1:1:1:1:1:1:1:1:1:1CompleatCompleat:HC396820860588043079845365780112888955819435219
U4/U6 x U5 tri-snRNP complexCD2BP2PPIHPRPF31PRPF6O43447O94906O95400Q8WWY31:1:1:1CompleatCompleat:HC12731078832095703131186754315840814
U5 small nuclear ribonucleoprotein complete complexCD2BP2DDX23EFTUD2PRPF6PRPF8SNRNP200SNRNP40SNRPBSNRPD1SNRPD2SNRPD3SNRPESNRPFSNRPGO75643O94906O95400P14678P62304P62306P62308P62314P62316P62318Q15029Q6P2Q9Q96DI7Q9BUQ81:1:1:1:1:1:1:1:1:1:1:1:1:1ComplexPortalPDBPDB:8q7xintact:EBI-61264911PDB:8RC0PDB:8q7wPDB:8rc0PDB:8Q9114755292384678773518858034131137
U5 snRNP complexAAR2CD2BP2DDX23EFTUD2LSM8PRPF8SNRNP200SNRPBSNRPD1SNRPD2SNRPD3SNRPESNRPFSNRPGSNRPNTXNL4ATXNL4BO75643O95400O95777P14678P62304P62306P62308P62314P62316P62318P63162P83876Q15029Q6P2Q9Q9BUQ8Q9NX01Q9Y3121:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1:1CompleatCompleat:HC312011720284
ARHGAP10ARHGAP26C2CD2A1A4S6Q9UNA1Q9Y4260:0:0hu.MAP
B7ZMF2FAAP100FANCAFANCBFANCCFANCD2FANCEFANCFFANCGFANCLUBE2TB7ZMF2O15287O15360Q00597Q0VG06Q8NB91Q9BXW9Q9HB96Q9NPD8Q9NPI8Q9NW381:2:2:1:2:2:1:1:1:1:2PDBPDB:7kzsPDB:7kzrPDB:7kzvPDB:7kzt
B7ZMF2FAAP100FANCAFANCBFANCCFANCD2FANCEFANCFFANCGFANCLB7ZMF2O15287O15360Q00597Q0VG06Q8NB91Q9BXW9Q9HB96Q9NPI8Q9NW381:2:2:1:2:2:1:1:1:2PDBPDB:7kzq
Page 6 of 13PreviousNext

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationMass spectrometry123161513
Sequence, Structure & Domains

Sequences

Length
351
Mass
39,448
Sequence
MSFPCKFVASFLLIFNVSSKGAVSKEITNALETWGALGQDINLDIPSFQMSDDIDDIKWEKTSDKKKIAQFRKEKETFKEKDTYKLFKNGTLKIKHLKTDDQDIYKVSIYDTKGKNVLEKIFDLKIQERVSKPKISWTCINTTLTCEVMNGTDPELNLYQDGKHLKLSQRVITHKWTTSLSAKFKCTAGNKVSKESSVEPVSCPEKGLDIYLIIGICGGGSLLMVFVALLVFYITKRKKQRSRRNDEELETRAHRVATEERGRKPHQIPASTPQNPATSQHPPPPPGHRSQAPSHRPPPPGHRVQHQPQKRPPAPSGTQVHQQKGPPLPRPRVQPKPPHGAAENSLSPSSN

3D Structural Models

Turn
88..90; 139..142
Helix
62..64; 73..75; 99..101
Beta Strand
31..36; 41..43; 52..61; 67..71; 77..80; 84..86; 92..94; 103..111; 116..127; 134..138; 143..147; 155..162; 164..170; 172..175; 180..189; 194..203
3D Structure
NMR spectroscopy (3); X-ray crystallography (4)

Domain & Motif Annotations

Compositional Bias
243..262; Basic and acidic residues; 269..280; Polar residues; 326..338; Pro residues
Domain (FT)
25..128; Ig-like V-type; 129..209; Ig-like C2-type
Region
61..75; CD58 binding region 1; 106..120; CD58 binding region 2; 237..351; Disordered
Clinical Relevance
Disease Involvement
FDA approved drug targets
Related Diseases
Biomarker
Phase 2; Discontinued in Phase 2
Drug Targets
FDA approved drug targets
Interaction Protein
ENSG00000140368ENSG00000147010ENSG00000169217ENSG00000198087
Interaction Count
4
Interaction Dataset
intact_biogrid